← Leaderboards
Thomas James Wandless
Stanford University
$7,587,677
Attributed
$7,587,677
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,587,677 · 5
By mechanism
R01$7,087,677 · 4
S10$500,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Helen M Blau$36,149,136
- Marco Conti$20,166,893
- Josh Tycko$432,794
- Edward S. Mocarski$11,996,025
- Kang Shen$9,140,678
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelCellsProteinsInterestTertiary Protein StructureGenesHuman DiseaseMutantDesignProtein FunctionMammalian CellPharmaceutical PreparationsSmall MoleculeTechnologyLigandsTacrolimus Binding ProteinsBiological ModelsMethodologyAffinityBiologicalEngineeringLifeProtein DegradationCell Physiology
Grant awards (25)
Regulated Protein Degradation$319,282
R01 · FY2023 · GM · contact PI
Regulated Protein Degradation$318,100
R01 · FY2022 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$321,000
R01 · FY2017 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$321,000
R01 · FY2016 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$321,000
R01 · FY2015 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$321,000
R01 · FY2014 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$304,486
R01 · FY2013 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$315,049
R01 · FY2012 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$314,582
R01 · FY2011 · GM · contact PI
LTQ Orbitrap XL ETD Mass Spectrometer$500,000
S10 · FY2010 · RR · contact PI
Conditional Protein Targeting$337,583
R01 · FY2010 · GM · contact PI
Novel Molecules as In Vivo Biological Probes$317,304
R01 · FY2010 · GM · contact PI
Conditional Protein Targeting$340,045
R01 · FY2009 · GM · contact PI
Novel molecules as in vivo biological probes$255,583
R01 · FY2009 · GM · contact PI
Conditional Protein Targeting$339,124
R01 · FY2008 · GM · contact PI
Novel molecules as in vivo biological probes$254,032
R01 · FY2008 · GM · contact PI
Conditional Protein Targeting$337,973
R01 · FY2007 · GM · contact PI
Novel molecules as in vivo biological probes$252,527
R01 · FY2007 · GM · contact PI
Novel molecules as in vivo biological probes$33,970
R01 · FY2007 · GM · contact PI
Conditional Protein Targeting$325,603
R01 · FY2006 · GM · contact PI
Novel molecules as in vivo biological probes$258,562
R01 · FY2006 · GM · contact PI
Conditional Protein Targeting$332,630
R01 · FY2005 · GM
Conditional Protein Targeting$331,844
R01 · FY2004 · GM
Conditional Protein Targeting$330,749
R01 · FY2003 · GM
ADVANCED ANTICANCER AGENTS THAT BIND TO MICROTUBULES$184,649
R01 · FY2000 · CA